Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian equity markets trade in green
Wed, 13 Nov 01:30 pm

Indian markets have recovered some losses and are trading above the dotted line during the post noon session. Barring stocks from IT, FMCG and capital goods, all the sectoral indices are trading in green. Most noticeable upward movement is witnessed in stocks from consumer durables and auto sectors.

BSE-Sensex is up by 78 points and NSE-Nifty is trading up by 22 points. While BSE Mid Cap is trading up by 0.04%, BSE Small Cap index is trading up by 0.02%. The rupee is trading at 63.53 to the US dollar.

Indian pharma stocks are trading mixed. Sun pharmaceuticals and Natco pharmaceuticals are among the leading gainers while Dishman and Ipca labs are leading among the pack of losers. Sun pharma's Israel based subsidiary Taro pharma declared results for the September quarter. Net sales increased by 27.5% YoY. On the operating front, EBITDA margins stood at 63% vs 54% in 2QFY13. This was helped by better gross product mix. The settlement and contingent expenses also declined during the quarter, this too helped in margin improvement. On the bottom line, PAT increased by 46% YoY. Better growth was also attributable to lower forex losses which were down by 70% YoY for the current quarter. Sun pharma is currently trading up by 3%.

Majority of the PSU banking stocks are trading in the green with Bank of Baroda and Bank of India being the major gainers. As per a leading financial daily, India's second largest PSU bank, Punjab national bank (PNB) said that it expects credit growth to reach 12-15% by this fiscal end from 2.5% last year. The growth is expected to be largely driven by demand from retail, agriculture and various other micro, medium and small enterprises. Reportedly, as per the bank's executive director, Rakesh Sethi, things are expected to improve and 2HFY14 will be much better than 1HFY14. Till 1HFY14, the company's credit growth has reached 7%. Further, the bank does not intend to raise lending rates as the cost of deposits has not gone up so far. The bank's Non Performing Assets (NPAs) have also remained at the same levels.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian equity markets trade in green". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE BANKEX


Mar 2, 2021 02:18 PM

S&P BSE BANKEX 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS